NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,442,939 | -3.2% | 107,504 | -1.4% | 1.22% | +1.5% |
| Q2 2023 | $10,791,190 | -2.9% | 109,057 | -8.3% | 1.20% | -11.1% |
| Q1 2023 | $11,115,052 | +6.4% | 118,903 | +5.0% | 1.35% | +1.4% |
| Q4 2022 | $10,447,136 | +29.8% | 113,199 | +7.0% | 1.33% | +13.4% |
| Q3 2022 | $8,046,000 | -0.7% | 105,813 | +9.3% | 1.17% | -2.7% |
| Q2 2022 | $8,105,000 | -0.5% | 96,805 | +7.8% | 1.21% | +8.2% |
| Q1 2022 | $8,144,000 | +22.9% | 89,837 | +21.8% | 1.12% | +23.6% |
| Q4 2021 | $6,624,000 | +31.0% | 73,767 | +19.3% | 0.90% | +11.5% |
| Q3 2021 | $5,056,000 | -8.3% | 61,827 | +2.3% | 0.81% | -12.2% |
| Q2 2021 | $5,516,000 | +22.0% | 60,460 | +15.8% | 0.92% | +9.5% |
| Q1 2021 | $4,521,000 | +6.8% | 52,194 | +16.4% | 0.84% | -12.8% |
| Q4 2020 | $4,234,000 | +25.3% | 44,836 | +15.3% | 0.96% | +5.2% |
| Q3 2020 | $3,380,000 | +9.0% | 38,871 | +9.5% | 0.92% | -10.9% |
| Q2 2020 | $3,100,000 | – | 35,491 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |